Tenax Therapeutics’ Post

It's #WorldPatientSafetyDay! This year's theme is all about improving diagnosis for patient safety with the powerful message "Get it right, make it safe!" For those affected by rare diseases like PSC, early and accurate diagnosis is crucial. At PSC Support, we are committed to advancing the future of diagnosis for PSC and improving the safety and lives of those affected by this complex liver disease. That's why we're proud to be funding Dr. Simon Rushbrook's ground-breaking research to develop a blood test for diagnosing PSC. This research has the potential to transform how quickly and accurately people with PSC can be diagnosed, helping patients receive the right care at the right time. Join us today in raising awareness of the vital role of correct and timely diagnosis in keeping patients safe. Together, we can make a difference! 💙 #GetItRightMakeItSafe #PatientSafety #PSCSupport #ResearchForPSC #RareDiseaseAwareness #ImprovingDiagnosis #LiverDiseaseResearch #PSCResearch #PatientCare #WorldPatientSafetyDay2024

Traditional real-world data, such as data from claims and EHRs, misses a big part of your patients’ stories. Join experts from Evidation and rheumission to hear case studies and best practices for filling important blanks, specifically in autoimmune disease: https://gag.gl/IZTIEm #webinar #autoimmunedisease #autoimmune #RWD #RWE

Traditional real-world data, such as data from claims and EHRs, misses a big part of your patients’ stories. Join experts from Evidation and rheumission to hear case studies and best practices for filling important blanks, specifically in autoimmune disease: https://gag.gl/IZTIEm #webinar #autoimmunedisease #autoimmune #RWD #RWE

1.7 million people live with diabetic macular edema (#DME) in the U.S., and about 700,000 are diagnosed and treated. With nearly a third of patients affected in both eyes, the demand for effective treatments to slow and reverse disease progression is more urgent than ever.     With #UBX1325, we aim to address this unmet need by offering a novel approach that may improve long-term visual outcomes for patients.     Hear more about our efforts to bring our senolytic candidate to patients from our CSO Alicia Tozier below.     Discover our scientific approach: https://bit.ly/4fMKjXp  

Traditional real-world data, such as data from claims and EHRs, misses a big part of your patients’ stories. Come hear case studies and best practices for filling important blanks, specifically in autoimmune disease: https://lnkd.in/eSqeHBcA #webinar #autoimmune #autoimmunedisease #rwd #realworlddata"

Lupus is an unpredictable and misunderstood autoimmune disease that ravages different parts of the body and affects an estimated 1.5 million Americans. This article explores innovative virtual care solutions that are reshaping how lupus is diagnosed and managed, offering new hope for those living with the disease. Discover how advancements in technology are making a significant impact on patient outcomes. Read more: https://lnkd.in/dNzmh6Gq Discover how we're transforming virtual care: https://lnkd.in/epNuqxyw 

Traditional real-world data, such as data from claims and EHRs, misses a big part of your patients’ stories. Come hear case studies and best practices for filling important blanks, specifically in autoimmune disease: https://lnkd.in/gWf4wauH #webinar #autoimmune #autoimmunedisease #rwd #realworlddata"

Traditional real-world data, such as data from claims and EHRs, misses a big part of your patients’ stories. Come hear case studies and best practices for filling important blanks, specifically in autoimmune disease: https://lnkd.in/ewxdvUDR #webinar #autoimmune #autoimmunedisease #rwd #realworlddata"

Traditional real-world data, such as data from claims and EHRs, misses a big part of your patients’ stories. Come hear case studies and best practices for filling important blanks, specifically in autoimmune disease: https://lnkd.in/gTxhtnhW #webinar #autoimmune #autoimmunedisease #rwd #realworlddata"

There are few things I like talking about more than the great work the RS BioTherapeutics, Inc. team is doing in developing our first-in-class, cannabis-based compound for the treatment of pulmonary inflammation-based diseases including COPD, IPF, and PAH. If you happen to have 30 minutes tomorrow, join us to hear more about our journey! #copd #ipf #pah #cannabismedicine #pulmonaryinflammation